Primary |
Drug Use For Unknown Indication |
39.5% |
Acute Myeloid Leukaemia |
11.6% |
Pseudomonas Infection |
11.6% |
Pneumonia |
9.3% |
Peritonitis |
4.7% |
Brain Abscess |
2.3% |
Cystic Fibrosis |
2.3% |
Diarrhoea |
2.3% |
Evidence Based Treatment |
2.3% |
Infection Prophylaxis |
2.3% |
Osteoporosis |
2.3% |
Product Used For Unknown Indication |
2.3% |
Prophylaxis |
2.3% |
Skin Infection |
2.3% |
Staphylococcal Infection |
2.3% |
|
Rash |
14.8% |
Drug Ineffective |
7.4% |
Medication Error |
7.4% |
Pancreatitis Acute |
7.4% |
Pruritus |
7.4% |
Confusional State |
3.7% |
Dehydration |
3.7% |
Hallucination |
3.7% |
Hepatic Enzyme Increased |
3.7% |
Infusion Site Irritation |
3.7% |
Ischaemia |
3.7% |
Meningitis Aseptic |
3.7% |
Muscle Contractions Involuntary |
3.7% |
Myoclonus |
3.7% |
Neurological Symptom |
3.7% |
Neutropenia |
3.7% |
Oral Discomfort |
3.7% |
Pharmaceutical Product Complaint |
3.7% |
Post Procedural Complication |
3.7% |
Product Packaging Quantity Issue |
3.7% |
|
Secondary |
Chronic Myeloid Leukaemia |
25.0% |
Peritoneal Dialysis |
25.0% |
Peritonitis |
25.0% |
Sepsis |
25.0% |
|
Rash Macular |
33.3% |
Drug Hypersensitivity |
16.7% |
Peritonitis Bacterial |
16.7% |
Respiratory Failure |
16.7% |
Syncope |
16.7% |
|
Concomitant |
Drug Use For Unknown Indication |
34.3% |
Product Used For Unknown Indication |
10.9% |
Pain |
8.5% |
Multiple Myeloma |
5.5% |
Nausea |
5.0% |
Sedation |
4.9% |
Acute Lymphocytic Leukaemia |
4.5% |
Prophylaxis |
4.2% |
Dry Skin |
2.8% |
Anti-infective Therapy |
2.3% |
Osteoporosis |
2.2% |
Anaemia |
2.1% |
Premedication |
1.9% |
Thrombosis Prophylaxis |
1.7% |
Depression |
1.6% |
Diuretic Therapy |
1.6% |
Hypertension |
1.6% |
Agitation |
1.5% |
Antiplatelet Therapy |
1.5% |
Acute Myeloid Leukaemia |
1.4% |
|
Wound Secretion |
17.6% |
Wound Infection Pseudomonas |
9.5% |
Injury |
6.8% |
Sepsis |
6.8% |
Weight Decreased |
6.8% |
Oedema Peripheral |
5.4% |
Vomiting |
5.4% |
Hypernatraemia |
4.1% |
Peritonitis Bacterial |
4.1% |
Renal Failure |
4.1% |
Transverse Sinus Thrombosis |
4.1% |
White Blood Cell Count Decreased |
4.1% |
Deep Vein Thrombosis |
2.7% |
Foot Fracture |
2.7% |
Haematochezia |
2.7% |
Hyperglycaemia |
2.7% |
Leukocytosis |
2.7% |
Pneumonitis |
2.7% |
Pyrexia |
2.7% |
Renal Failure Chronic |
2.7% |
|